IL95936A - ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it - Google Patents

) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it

Info

Publication number
IL95936A
IL95936A IL9593690A IL9593690A IL95936A IL 95936 A IL95936 A IL 95936A IL 9593690 A IL9593690 A IL 9593690A IL 9593690 A IL9593690 A IL 9593690A IL 95936 A IL95936 A IL 95936A
Authority
IL
Israel
Prior art keywords
compound
hydroxy
phenylbutoxy
benzenedimethanol
hexyl
Prior art date
Application number
IL9593690A
Other languages
English (en)
Hebrew (he)
Other versions
IL95936A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898922795A external-priority patent/GB8922795D0/en
Priority claimed from GB909012472A external-priority patent/GB9012472D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL95936A0 publication Critical patent/IL95936A0/xx
Publication of IL95936A publication Critical patent/IL95936A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9593690A 1989-10-10 1990-10-09 ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it IL95936A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898922795A GB8922795D0 (en) 1989-10-10 1989-10-10 Chemical compounds
GB909012472A GB9012472D0 (en) 1990-06-05 1990-06-05 Chemical compounds

Publications (2)

Publication Number Publication Date
IL95936A0 IL95936A0 (en) 1991-07-18
IL95936A true IL95936A (en) 1996-01-19

Family

ID=26296026

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9593690A IL95936A (en) 1989-10-10 1990-10-09 ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it

Country Status (10)

Country Link
EP (1) EP0422889A3 (fr)
JP (1) JPH03133946A (fr)
KR (1) KR100192622B1 (fr)
AU (1) AU629989B2 (fr)
CA (1) CA2027262A1 (fr)
IE (1) IE903614A1 (fr)
IL (1) IL95936A (fr)
NZ (1) NZ235605A (fr)
PT (1) PT95542B (fr)
TW (1) TW209832B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919827A (en) * 1990-07-11 1999-07-06 Sepracor Inc. Method for treating asthma using optically pure R(-) salmeterol
GB9215274D0 (en) * 1992-07-17 1992-09-02 Scras Derivatives of(phenylethyl-beta-ol)amine
ES2065269B1 (es) * 1993-05-11 1995-10-01 S A L V A T Lab Sa 6-(4-(fenilbutoxi) hexilaminometil-4-hidroxi-a1,a3-bencenodimetanol. procedimiento para la obtencion del mismo y nuevos intermedios utilizados en su preparacion.
CA2177171C (fr) * 1993-12-10 2006-01-17 Alfred Sallmann Nouvelles oxazolidines substituees
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
GB0014546D0 (en) * 2000-06-14 2000-08-09 Glaxo Group Ltd A novel process
GB0105560D0 (en) * 2001-03-07 2001-04-25 Glaxo Group Ltd Pharmaceutical formulations
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
WO2007045857A1 (fr) 2005-10-17 2007-04-26 Generics (Uk) Limited Procede nouveau
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
WO2016142582A1 (fr) 2015-03-11 2016-09-15 Fermion Oy Procédé de préparation de salmétérol cristallin et de son sel de xinafoate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB8310477D0 (en) * 1983-04-18 1983-05-25 Glaxo Group Ltd Chemical compounds
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
DE3806321A1 (de) * 1988-02-27 1989-09-07 Boehringer Mannheim Gmbh Neue trisubstituierte amine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
KR910007867A (ko) 1991-05-30
AU6390190A (en) 1991-04-18
EP0422889A2 (fr) 1991-04-17
IL95936A0 (en) 1991-07-18
JPH03133946A (ja) 1991-06-07
AU629989B2 (en) 1992-10-15
PT95542B (pt) 1999-09-30
PT95542A (pt) 1991-08-14
TW209832B (fr) 1993-07-21
KR100192622B1 (ko) 1999-06-15
CA2027262A1 (fr) 1991-04-11
EP0422889A3 (en) 1991-08-28
IE903614A1 (en) 1991-04-24
NZ235605A (en) 1992-12-23

Similar Documents

Publication Publication Date Title
IL95936A (en) ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it
EP0210849B1 (fr) 2-Hydroxy-3-phénoxypropylamines
EP0261254A1 (fr) Dérivés d'acides 3,4-dihydro-4-oxo-2H-1-benzopyranyloxy-alkanoiques
US4977146A (en) 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
EP0034461A1 (fr) Composés aromatiques d'aminoéthanol et leurs sels, compositions pharmaceutiques les contenant et procédés pour leur production
EP0072061A1 (fr) Dérivés d'amines, procédés pour leur production et compositions pharmaceutiques les contenant
IE883846L (en) Propoxybenzene derivatives and process for preparing the same
EP0772585A1 (fr) Derives d'aryloxy- et d'arylthiopropanolamine utiles en tant qu'agonistes d'adrenorecepteurs beta 3 et qu'antagonistes des adrenorecepteurs beta 1 et beta 2 et composition pharmaceutique
GB2174702A (en) Cyclopentyl ethes and their preparation and pharmaceutical formulation
AU635424B2 (en) Dichloroaniline compound
US5066678A (en) Phenethandamine derivatives and pharmaceutical use thereof
IL87246A (en) Process for the production of unsaturated derivatives of 2-amino-alkanoic acid containing phosphorus, new compounds and pharmaceutical preparations containing them
EP0467435A2 (fr) Dérivés de benzhydryl qui sont inhibiteurs de calmodulin
US5134134A (en) Unsaturated aminodicarboxylic acid derivatives
GB2230523A (en) 1-(3-Bromoisoxazol-5-yl)-2-aminoethanol derivatives
US5476952A (en) Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives
US4292444A (en) Sulfonyl prostaglandin carboxamide derivatives
EP0542671A1 (fr) Dérivés d'hydroquinone substitués comme intermédiaires pour la préparation de dérivés de benzofuranne
WO1981003021A1 (fr) Derives de bis-hydroxybenzyle, leur procede de preparation et composition pharmaceutique les contenant
GB2162845A (en) Phenethanolamine derivatives
GB2230775A (en) Phenethanolamine compounds
JPH10212232A (ja) ジアリールアルカン誘導体を有効成分とする膵炎治療剤又は予防剤
GB2230524A (en) Alpha-piperidine-2-yl- and alpha-pyrrolidin-2-yl benzyl alcohol derivatives
CA2075485A1 (fr) Derives de thioformamide
WO1999054278A1 (fr) CETONES INSATUREES 1-(2-ALCOXY-5-CARBOXYPHENYL)-α,β, ELABORATION, ET APPLICATION THERAPEUTIQUE

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void